NPPA extends time limit for submission of production, price data in IPDMS 2.0

New Delhi, October 28, 2022:

The National Pharmaceutical Pricing Authority (NPPA) has extended the last date of filing statutory forms related to details of price list and quarterly returns prescribed under the Drugs (Prices Control) Order, 2013 for drugs and medical devices.

The move comes after the Authority received several representations from the industry requesting for extension of last date for filing the statutory Form III (for submission of quarterly return in respect of production/import and sale data for drugs under the National List of Essential Medicines), Form V (which is an intimation about the Maximum Retail Price change of scheduled and non-scheduled drugs), and Form VI (which is to intimate the Authority regarding the MRP change of medical devices).

“Several representations requesting for extension of last date for filing statutory Forms - III, V and VI as prescribed under DPCO, 2013 in integrated Pharmaceutical Database Management System (IPDMS) 2.0 have been received from industry associations/companies,” said the Authority in an Office Memorandum. The authority has examined the matter and the time limit has been extended, said the OM with further details.

While the data under Form III has to be submitted within fifteen days from the end of the quarter, as per the rules, for the quarter ending September, 2022, it can be filed up to December 31, 2022.

Similarly, for any MRP revision done between August 1 to December 15, 2022, the Form V can be filed up to December 31, 2022, as against the previous time limit of fifteen days from the date of price revision.

Under the Form VI, which was inserted by the Department of Pharmaceutical through an order on July 20, 2021, for the intimation about MRP change of medical devices, has to be filed within a period of fifteen days of price revision, according to the price regulation. The NPPA, through the office memorandum, stated that for any MRP revision done between August 1 and December 15, 2022, the Form VI can be filed up to December 31, 2022.

According to reports, the NPPA has in the past also issued orders extending the time limit for submission of the Forms related to the production and sales and price data for drugs and medical devices in response to the requests from the industry.

The IPDMS 2.0 is implemented by the NPPA for online information collection from pharmaceutical manufacturers to monitor and regulate the pharma and medical devices prices, to ensure availability and affordability of drugs and medical devices in the country. Pharmabiz